机译:将无细胞miR-198的下调作为肺腺癌相关恶性胸腔积液的诊断生物标志物
Department of Internal Medicine College of Medicine Chungbuk National University Cheongju South;
Department of Bioevaluation Center Korea Research Institute of Bioscience and Biotechnology;
Department of Internal Medicine College of Medicine Chungbuk National University Cheongju South;
Department of Internal Medicine College of Medicine Chungbuk National University Cheongju South;
Department of Internal Medicine College of Medicine Chungbuk National University Cheongju South;
Department of Internal Medicine College of Medicine Chungbuk National University Cheongju South;
Department of Radiology College of Medicine Chungbuk National University Cheongju South Korea;
Department of Pathology College of Medicine Chungbuk National University 776 1Sunhwan-ro;
Department of Pathology College of Medicine Chungbuk National University 776 1Sunhwan-ro;
Department of Pathology College of Medicine Chungbuk National University 776 1Sunhwan-ro;
Department of Urology College of Medicine Chungbuk National University Cheongju South Korea;
Department of Urology College of Medicine Chungbuk National University Cheongju South Korea;
Department of Pathology College of Medicine Chungbuk National University 776 1Sunhwan-ro;
CEA; CYFRA 21-1; lung adenocarcinoma; miR-198; pleural effusion;
机译:将无细胞miR-198的下调作为肺腺癌相关恶性胸腔积液的诊断生物标志物
机译:CD66c在肺腺癌相关的恶性胸腔积液中的诊断性能:与CEA,CA 19-9和CYFRA 21-1的比较
机译:6595 POSTER Her-2 / neu,Cyfra 21-1和CEA在肺腺癌相关恶性胸腔积液中的诊断准确性和临界点
机译:靶向蛋白质组学管道揭示了潜在的生物标志物,用于诊断胸腔积液中转移性肺癌
机译:帽依赖性翻译在恶性胸膜间皮瘤和非小细胞肺癌中的作用。
机译:循环细胞外miR-134miR-185和miR-22水平在肺腺癌相关恶性胸腔积液中的诊断价值
机译:将无细胞miR-198的下调作为肺腺癌相关恶性胸腔积液的诊断生物标志物